首页> 外文期刊>Bioelectrochemistry >A theranostic system based on nanocomposites of manganese oxide nanoparticles and a pH sensitive polymer: Preparation, and physicochemical characterization
【24h】

A theranostic system based on nanocomposites of manganese oxide nanoparticles and a pH sensitive polymer: Preparation, and physicochemical characterization

机译:一种基于氧化锰纳米粒子纳米复合材料的治疗系统及pH敏感聚合物:制备和物理化学表征

获取原文
获取原文并翻译 | 示例
           

摘要

A multifunctional nanocomposite theranostic system is constructed of manganese oxide (Mn3O4) nanoparticles (NPs), as a tumor diagnostic agent, in conjunction with polyacrylic acid (PM), as a pH-sensitive drug delivery agent, and methotrexate (MTX), as a model of targeting agent and anticancer drug, Physicochemical characteristics of the Mn3O4@PAA/MTX system is studied in detail by several techniques, including X-ray and Auger photoelectron spectroscopy, Fourier transform infrared spectroscopy, X-ray diffraction, field-emission scanning electron microscopy, transmission electron microscopy, and electrochemical methods. The system performance is studied based on (i) in-vitro MRI measurements to support efficiency of the Mn3O4@PAA NPs as a diagnostic agent, (ii) drug release performance of the Mn3O4@PAA/MTX NPs at pHs of 5.4 and 7.4 through in-vitro method to evaluate application of the NPs as pH-sensitive nanocarriers for MTX, and (iii) impedance spectroscopy measurements to show Mn3O4@PAA/MTX NPs affinity for capturing of cancer cells. The results show that (i) Mn3O4@PAA NPs can be used as a contrast agent in MRI measurements (r(1 congruent to )6.5 mM(-1)s(-1)), (ii) the MTX, loaded on Mn3O4@PAA NPs, is released faster and more efficient at pH 5.4 than 7.4, and (iii) the GC-Mn3O4@PAA/MTX electrode system captures the 4T1 cells 3.32 times larger than L929 cells. (C) 2019 Published by Elsevier B.V.
机译:多官能纳米复合体静体系由氧化锰(MN3O4)纳米颗粒(NPS)构成,作为肿瘤诊断剂,与聚丙烯酸(PM)相结合,作为pH敏感的药物递送剂和甲氨蝶呤(MTX),为a靶向剂和抗癌药物的模型,通过多种技术详细研究了MN3O4 @ PAA / MTX系统的物理化学特性,包括X射线和螺旋钻光电子能,傅里叶变换红外光谱,X射线衍射,现场 - 发射扫描电子显微镜,透射电子显微镜和电化学方法。基于(i)体外MRI测量研究了系统性能,以支持MN3O4 @ Paa NPS作为诊断剂的效率,(ii)在5.4和7.4的pHS下的Mn3O4 @ Paa / MTX NP的药物释放性能在体外方法中评估NPS作为MTX的pH敏感纳米载体的应用,(III)阻抗光谱测量以显示用于捕获癌细胞的MN3O4 @ PAA / MTX NPS亲和力。结果表明,(i)MN3O4 @ PAA NPS可以用作MRI测量中的造影剂(R(1一致为)6.5 mm(-1)S(-1)),(ii)MTX,在MN3O4上加载@PAA NPS,在pH 5.4的pH 5.4时释放得更快,更高效,(iii)GC-MN3O4 @ PAA / MTX电极系统捕获4T1电池的3.32倍大于L929细胞。 (c)2019年由elestvier b.v发布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号